Endostatin induces autophagic cell death in EAhy926 human endothelial cells

Histology and Histopathology

Volumn 18, Issue 3, 2003, Pages 715-726

  Chau, Yat Pang ^a   Lin, S Y ^a   Chen, J H C ^b   Tai, Ming Hong ^b,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Autophagic cell death; Endostatin; Human endothelial cell; Lysosomal protease

Indexed keywords

3 METHYLADENINE; ACETYLASPARTYLGLUTAMYLVALYLASPARTYL ALDEHYDE; ACETYLTYROSYLVALYLALANYLASPARTYL ALDEHYDE; ALPHA TOCOPHEROL; ANTIOXIDANT; APROTININ; ASCORBIC ACID; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BREFELDIN A; CASPASE; CASPASE INHIBITOR; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; ENDOSTATIN; GALLIC ACID PROPYL ESTER; LEUPEPTIN; PEPSTATIN; REACTIVE OXYGEN METABOLITE; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL DEATH; CELL LINE; CELL VACUOLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; TUMOR VASCULARIZATION;

ACRIDINE ORANGE; ADENINE; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; APROTININ; BLOTTING, WESTERN; CASPASES; CELL DEATH; CELLS, CULTURED; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; CYSTEINE; CYSTEINE ENDOPEPTIDASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOSTATINS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; FLOW CYTOMETRY; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOHISTOCHEMISTRY; LEUPEPTINS; LYSOSOMES; MICROSCOPY, ELECTRON; MICROSCOPY, PHASE-CONTRAST; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS; SERINE; TIME FACTORS;

EID: 0038127194     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Afford S. and Randhawa S. (2000). Apoptosis. Mol. Pathol. 53, 55-63.
2. Aubert S., Gout E., Bligny R., Marty-Mazars D., Barrieu F., Alabouvette J., Marty F. and Douce R. (1996). Ultrastructural and biochemical characterization of autography in higher plant cells subjected to carbon deprivation: Control by the supply of mitochondria with respiratory substrates. J. Cell Biol. 133, 1251-1263.
3. Augustin H.G. (1998). Antiangiogenic tumour therapy: Will it work?. Trends Pharmacol. Sci. 19, 216-222.
4. Bergers G., Javaherian K., Lo K.M., Folkman J. and Hanahan D. (1999). Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284, 808-812.
5. Brunk U.T. and Svensson I. (1999). Oxidative stress, growth factor starvation and Fas activation may all cause apoptosis through lysosomal leak. Redox Report 4, 3-11.
6. Bruns C.J., Liu W., Davis D.W., Shaheen R.M., McConkey D.J., Wilson M.R., Bucana C.D., Hicklin D.J. and Ellis L.M. (2000). Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases. Cancer 89, 488-499.
7. Bursch W., Ellinger A., Gerner C., Frohwein U. and Schulte-Hermann R. (2000). Programmed cell death (PCD). Apoptosis, autophagic PCD, or others? Ann. NY Acad. Sci. 926, 1-12.
8. Chen Q.R., Kumar D., Stass S.A. and Mixson A.J. (1999). Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice. Cancer Res. 59, 3308-3312.
9. Clement B., Musso O., Lietard J. and Theret N. (1999). Homeostatic control of angiogenesis: A newly identified function of the liver? Hepatology 29, 621-623.
10. Dhanabal M., Ramchandran R., Waterman M.J., Lu H., Knebelmann B., Segal M. and Sukhatme V.P. (1999). Endostatin induces endothelial cell apoptosis. J. Biol. Chem. 274, 11721-11726.
11. Dixelius J., Larsson H., Sasaki T., Holmqvist K., Lu L., Engstrom A., Timpl-Welsh M. and Claesson-Welsh L. (2000). Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis. Blood 95, 3403-3411.
12. Edgell C.J., McDonald C.C. and Graham J.B. (1983). Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. USA 80, 3734-3737.
13. Ferrara N. and Alitalo K. (1999). Clinical applications of angiogenic growth factors and their inhibitors. Nat. Med. 5, 1359-1364.
14. Folkman J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31.
15. Folkman J. (1996). Tumor angiogenesis and tissue factor. Nat. Med. 2, 167-168.
16. Gasparini G. (1999). The rationale and future potential of angiogenesis inhibitors in neoplasia. Drugs 58, 17-38.
17. Hanahan D. and Folkman J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364.
18. Harris A.L. (1998). Are angiotensin and endostatin cures for cancer?. Lancet 351, 1598-1599.
19. Haynes M.P., Sinha D., Russell K.S., Collinge M., Fulton D., Morales-Ruiz M., Sessa W.C. and Bender J.R. (2000). Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ. Res. 87, 677-682.
20. Isahara K., Ohsawa Y., Kanamori S., Shibata M., Waguri S., Sato N., Gotow T., Watanabe T., Momoi T., Urase K., Kominami E. and Uchiyama Y. (1999). Regulation of a novel pathway for cell death by lysosomal aspartic and cysteine proteinases. Neuroscience 91, 233-249.
21. Jia L., Dourmashkin R.R., Allen P.D., Gray A.B., Newland A.C. and Kelsey S.M. (1997). Inhibition of autophagy abrogates tumour necrosis factor alpha induced apoptosis in human T-lymphoblastic leukaemic cells. B. J. Haematol. 98, 673-685.
22. Kafienah W., Bromme D., Buttle D.J., Croucher L.J. and Hollander A.P. (1998a). Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem. J. 331, 727-732.
23. Kafienah W., Buttle D.J., Burnett D. and Hollander A.P. (1998b). Cleavage of native type I collagen by human neutrophil elastase. Biochem. J. 330, 897-902.
24. Kim J., Huang W.P. and Klionsky D.J. (2001). Membrane recruitment of Aut7p in the autophagy and cytoplasm to vacuole targeting pathway requires Aut1p, Aut2p, and the autophagy conjugation complex. J. Cell Biol. 152, 51-64.
25. Kim Y.M., Hwang S., Kim Y.M., Pyun B.J., Kim T.Y., Lee S.T., Gho Y.S. and Kwon Y.G. (2002). Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J. Biol. Chem. 277, 27872-27879.
26. Klionsky D.J. and Emr S.D. (2000). Autophagy as a regulated pathway of cellular degradation. Science, 290, 1717-1721.
27. Larsen K.E. and Sulzer D. (2002) Autophagy ain neurons: A review. Histol. Histopathol. 17, 897-908.
28. Lee S.J., Jang J.W., Kim Y.M., Lee H.I., Jeon J.Y., Kwon Y.G. and Lee S.T. (2002). Endostatin binds to the catalytic domain of matrix metalloproteinase-2. FEBS Lett. 519, 147-152.
29. Lemasters J.J., Nieminen A.L., Qian T., Trost L.C., Elmore S.P., Nishimura Y., Crowe R.A., Cascio W.E., Bradham C.A., Brenner D.A. and Herman B. (1998). The mitochondrial permeability transition in cell death: A common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta 1366, 177-196.
30. Liang X.H., Jackon S., Seaman M., Brown K., Kempkes B., Hibshoosh H. and Levine B. (1999). Introduction by autophagy and inhibition of tumorigenesis by beclin 1. Nature 402, 672-676.
31. Liou W., Geuze H.J., Geelen M.J. and Slot J.W. (1997). The autophagic and endocytic pathways converge at the nascent autophagic vacuoles. J. Cell Biol. 136, 61-70.
32. Maciewicz R.A. and Etherington D.J. (1988). A comparison of four cathepsins (B, L, N and S) with collagenolytic activity from rabbit spleen. Biochem. J. 256, 433-440.
33. Moulton K.S., Heller E., Konerding M.A., Flynn E., Palinski W. and Folkman J. (1999). Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 99, 1726-1732.
34. Muller L., Valdenaire O., Barret A., Korth P., Pinet F., Corvol P., and Tougard C. (2000). Expression of the endothelin-converting enzyme-1 isoforms in endothelial cells. J. Cardiovasc. Pharmacol. 36, S15-S18.
35. Nilsson E., Ghassemifar, R. and Brunk, U.T. (1997). Lysosomal heterogeneity between and within cells with respect to resistance against oxidative stress. Histochem. J. 29, 857-865.
36. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R. and Folkman J. (1997). Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285.
37. Oehler M.K., Bicknell R. (2000) 82, 749-752.
38. Olejnicka B.T., Dalen H. and Brunk U.T. (1999). Minute oxidative stress is sufficient to induce apoptotic death of NIT-1 insulinoma cells. APMIS 107, 747-761.
39. Perletti G., Concari P., Giardini R., Marras E., Piccinini F., Folkman J. and Chen L. (2000). Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors. Cancer Res. 60, 1793-1796.
40. Petersen A., Larsen K.E., Behr G.G., Romero N., Przedborski S., Brundin P. and Sulzer D. (2001). Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration. Hum. Mol. Genet. 10, 1243-1254.
41. Reipert S., Berry J., Hughes M.F., Hickman J.A. and Allen T.D. (1995). Changes of mitochondrial mass in the hemopoietic stem cell line FDCP-mix after treatment with etoposide: A correlative study by multiparameter flow cytometry and confocal and electron microscopy. Exp. Cell Res. 221, 281-288.
42. Risau W. (1997). Mechanisms of angiogenesis. Nature 386, 671-674.
43. Saarela J., Ylikarppa R., Rehn M., Purmonen S. and Pihlajaniemi T. (1998). Complete primary structure of two variant forms of human type XVII collagen and tissue-specific differences in the expression of the corresponding transcripts. Matrix Biol. 16, 319-28.
44. Shichiri M. and Hirata Y. (2001). Antiangiogenesis signals by endostatin. FASEB J. 6, 1044-1053.
45. Starkey P.M. (1977). The effect of human neutrophil elastase and cathepsin Gon the collagen of cartilage, tendon, and cornea. Acta Biol. German 36, 1549-1554.
46. Strasser A., O'Connor L. and Dixit V.M. (2000). Apoptosis signaling. Annu. Rev. Biochem. 69, 217-245.
47. Stula M., Orzechowski H.D., Gschwend S., Vetter R., Von Harsdorf R., Dietz R. and Paul M. (2000). Influence of sustained mechanical stress on Egr-1 mRNA expression in cultured human endothelial cells. Mol. Cell. Biochem. 210, 101-108.
48. Van Oost B.A., Edgell C.J., Hay C.W. and MacGillivray R.T. (1986). Isolation of a human von Willebrand factor cDNA frm the hybrid endotheial cel line EAhy926. Biochem. Cell. Biol. 64, 699-705.
49. Wickstrom S.A., Alitalo K. and Keski-Oja J. (2002). Endostatin associates with integrin alpha5beta1 and caveolin-1, and activates Src via tyrosyl phosphatase-dependent pathway in human endothelial cells. Cancer Res. 1, 5580-5589.
50. Yokoyma Y., Green J.E., Sukhatme V.P. and Ramakrishnan S. (200). Effect of endostatin on spontaneous tumorigenesis of mammary adenocarcinoma in a transenic mouse model. Cancer Res. 60, 4362-4365.
51. Yue Z., Horton A., Bravin M., Dejager P.L., Selimi F. and Heintz N. (2002). A novel protien complex linking the delta 2 glutamate receptor and autophagy: Implications for neurodegeneration in lucher mice. Neuron 35, 921-933.
52. Zatterstrom UK., Felbor U., Fukai N. and Olser B.R. (2000). Collagen XVIII/endostatin structure and functional role in angiogenesis. Cell Struct. Funct. 25, 97-101.